Literature DB >> 8264454

The Diabetes Control and Complications Trial (DCCT). A milestone in diabetes management.

D J Chrisholm1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8264454

Source DB:  PubMed          Journal:  Med J Aust        ISSN： 0025-729X            Impact factor:   7.738


× No keyword cloud information.
  6 in total

Review 1.  Inflammation as a Therapeutic Target for Diabetic Neuropathies.

Authors:  Rodica Pop-Busui; Lynn Ang; Crystal Holmes; Katherine Gallagher; Eva L Feldman
Journal:  Curr Diab Rep       Date:  2016-03       Impact factor: 4.810

Review 2.  Bioenergetics in diabetic neuropathy: what we need to know.

Authors:  Lucy M Hinder; Andrea M Vincent; Charles F Burant; Subramaniam Pennathur; Eva L Feldman
Journal:  J Peripher Nerv Syst       Date:  2012-05       Impact factor: 3.494

3.  Development and progression of diabetic retinopathy and associated risk factors in Korean patients with type 2 diabetes: the experience of a tertiary center.

Authors:  Yoon Jeon Kim; June-Gone Kim; Joo Yong Lee; Kyoung Sub Lee; Soo Geun Joe; Joong-Yeol Park; Min-Seon Kim; Young Hee Yoon
Journal:  J Korean Med Sci       Date:  2014-11-21       Impact factor: 2.153

4.  Elevated triglycerides correlate with progression of diabetic neuropathy.

Authors:  Timothy D Wiggin; Kelli A Sullivan; Rodica Pop-Busui; Antonino Amato; Anders A F Sima; Eva L Feldman
Journal:  Diabetes       Date:  2009-05-01       Impact factor: 9.461

5.  Monoconjugation of Human Amylin with Methylpolyethyleneglycol.

Authors:  Tháyna Sisnande; Luiz Henrique Guerreiro; Raquel R Braga; Luana Jotha-Mattos; Luiza C S Erthal; Priscilla Tinoco; Bruno M Ferreira; Luís Maurício T R Lima
Journal:  PLoS One       Date:  2015-10-08       Impact factor: 3.240

6.  The genetics of diabetic nephropathy.

Authors:  Eoin Brennan; Caitríona McEvoy; Denise Sadlier; Catherine Godson; Finian Martin
Journal:  Genes (Basel)       Date:  2013-11-05       Impact factor: 4.096
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.